What is the current Price Target for the ZIOPHARM Oncology, Inc. stock?

The average ZIOPHARM Oncology, Inc. target price is $3.06. This is 180.73% higher than the current stock price. The highest price target is 622.48%, the lowest is 38.99%. 7 Analysts have issued a price target ZIOPHARM Oncology, Inc. 2027 .

How high will the ZIOPHARM Oncology, Inc. stock rise?

No reliable answer can be given as to how high the ZIOPHARM Oncology, Inc. stock will rise. The performance of stocks, including the ZIOPHARM Oncology, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the ZIOPHARM Oncology, Inc. stock today?

The performance of ZIOPHARM Oncology, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the ZIOPHARM Oncology, Inc. stock fall?

The decline in ZIOPHARM Oncology, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

ZIOPHARM Oncology, Inc. Forecast, price target & analysts

$1.09

3.54%

Nasdaq, Sep 25, 04:22 pm EDT. Closed.

ISIN

US98973P1012

Symbol

TCRT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

ZIOPHARM Oncology, Inc. Target price 2026 - Analyst rating & recommendation

ZIOPHARM Oncology, Inc. Classifications & Recommendation

Hold

50%

Sell

50%

ZIOPHARM Oncology, Inc. Price Target

Target Price	$3.06
Price	$1.09
Potential	180.73% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target ZIOPHARM Oncology, Inc. 2027 . The average ZIOPHARM Oncology, Inc. target price is $3.06. This is 180.73% register free of charge higher than the current stock price. The highest price target is $7.88 622.48% register free of charge , the lowest is $1.52 38.99% register free of charge .
	A rating was issued by 6 analysts: 0 Analysts recommend ZIOPHARM Oncology, Inc. to buy, 3 to hold and 3 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the ZIOPHARM Oncology, Inc. stock has an average upside potential 2027 of 180.73% register free of charge . Most analysts recommend the ZIOPHARM Oncology, Inc. stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-2.14	-0.14
	26.71%	93.46%
P/E		negative

3 Analysts have issued a ZIOPHARM Oncology, Inc. forecast for earnings per share. The average ZIOPHARM Oncology, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-2.14	26.71%
2026	$-0.14 93.46% unlock

Current	-0.66	34.64%
2026	-7.63 1,048.06% unlock

ZIOPHARM Oncology, Inc....

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now